Larvol Delta - Asgard-Therapeutics-to-present-preclinical-data-on-lead-asset-AT108-a-personalized-offtheshelf-gene-therapy-at-AACR-Annual-Meeting-2026

AT108 - Asgard Therapeutics

https://www.globenewswire.com/news-release/2026/04/17/3276450/0/en/Asgard-Therapeutics-to-present-preclinical-data-on-lead-asset-AT-108-a-personalized-off-the-shelf-gene-therapy-at-AACR-Annual-Meeting-2026.html

Apr 17, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next